You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
McKesson
McKinsey
Baxter
Moodys

Last Updated: March 4, 2021

DrugPatentWatch Database Preview

Terazosin hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for terazosin hydrochloride and what is the scope of patent protection?

Terazosin hydrochloride is the generic ingredient in two branded drugs marketed by Abbott, Apnar Pharma Lp, Beximco Pharms Usa, Heritage Pharma, Hikma, Jubilant Cadista, Mylan, Mylan Technologies, Ranbaxy Labs Ltd, Ivax Sub Teva Pharms, Sandoz, and Teva, and is included in fourteen NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-four drug master file entries for terazosin hydrochloride. Nineteen suppliers are listed for this compound.

Summary for terazosin hydrochloride
US Patents:0
Tradenames:2
Applicants:12
NDAs:14
Drug Master File Entries: 24
Suppliers / Packagers: 19
Bulk Api Vendors: 67
Clinical Trials: 22
Patent Applications: 1,281
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in terazosin hydrochloride?terazosin hydrochloride excipients list
DailyMed Link:terazosin hydrochloride at DailyMed
Recent Clinical Trials for terazosin hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Qiang ZhangPhase 1
University of IowaPhase 1
Michael J. Fox Foundation for Parkinson's ResearchPhase 1

See all terazosin hydrochloride clinical trials

Pharmacology for terazosin hydrochloride
Paragraph IV (Patent) Challenges for TERAZOSIN HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
HYTRIN TABLET;ORAL terazosin hydrochloride 019057
HYTRIN CAPSULE;ORAL terazosin hydrochloride 020347

US Patents and Regulatory Information for terazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apnar Pharma Lp TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 074823-002 Mar 30, 1998 AB RX No No   Start Trial   Start Trial   Start Trial
Teva TERAZOSIN HYDROCHLORIDE terazosin hydrochloride TABLET;ORAL 074446-002 May 18, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-001 Aug 7, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Jubilant Cadista TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075317-003 Dec 20, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Beximco Pharms Usa TERAZOSIN HYDROCHLORIDE terazosin hydrochloride CAPSULE;ORAL 075667-004 Jul 28, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for terazosin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-001 Aug 7, 1987   Start Trial   Start Trial
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987   Start Trial   Start Trial
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-004 Dec 14, 1994   Start Trial   Start Trial
Abbott HYTRIN terazosin hydrochloride CAPSULE;ORAL 020347-003 Dec 14, 1994   Start Trial   Start Trial
Abbott HYTRIN terazosin hydrochloride TABLET;ORAL 019057-003 Aug 7, 1987   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Colorcon
Harvard Business School
Express Scripts
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.